Subjects: Opioid-Related Disorders -- drug therapy / Genre: Technical Report - Digital Collections - National Library of Medicine Search Results

Start Over Subjects Opioid-Related Disorders -- drug therapy ✖ Genre Technical Report ✖

31. The risk of misuse and diversion of buprenorphine for opioid use disorder in Medicare Part D continues to appear low: 2022

Publication:: [Washington, D.C.] : U.S. Department of Health and Human Services, Office of Inspector General, November 2023
Subject(s):: Buprenorphine
Drug Users -- statistics & numerical data
Government Regulation
Medicare Part D -- economics
Opiate Substitution Treatment
Opioid-Related Disorders -- drug therapy
Prescription Drug Diversion -- statistics & numerical data
United States

32. The consistently low percentage of Medicare enrollees receiving medication to treat their opioid use disorder remains a concern

Publication:: Washington, D.C. : U.S. Department of Health and Human Services, Office of Inspector General, December 2023
Subject(s):: Government Regulation
Medicare
Opiate Overdose -- prevention & control
Opiate Substitution Treatment
Opioid-Related Disorders -- drug therapy
United States

33. How community health centers are addressing the opioid epidemic: case study

Author(s):: Hayes, Robert M., author
Squitieri, Joseph, author
Publication:: New York, NY : Milbank Memorial Fund, April 2019
Subject(s):: Child of Impaired Parents
Community Health Centers
Community Health Services
Opiate Substitution Treatment
Opioid-Related Disorders -- drug therapy
Adolescent
Buprenorphine, Naloxone Drug Combination -- therapeutic use
Child
Community Mental Health Services
Drug Overdose -- prevention & control
Humans
United States